Humana Inc.

HUM

US4448591028

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Employees

67,600

Sector

Managed Healthcare

Calendar

12/09/2024 - Investor Meeting - Nephron Research clients

Related indices

S&P 500

More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

Humana, an insurance company that doesn't lack appeal

February 02, 2023 at 08:45 pm IST

More Strategies

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

357.86USD

Average target price

393.73USD

Spread / Average Target

+10.02%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 01:30:02 07/09/2024 am IST			5-day change	1st Jan Change
357.86 ^USD	-1.99%		+0.96%	-21.83%

05/09	RBC Raises Price Target on Humana to $400 From $385, Maintains Outperform Rating	MT
05/09	Analyst recommendations: Booking Holdings, Humana, Dollar Tree, Lloyds Banking Group...

RBC Raises Price Target on Humana to $400 From $385, Maintains Outperform Rating	05/09	MT
Analyst recommendations: Booking Holdings, Humana, Dollar Tree, Lloyds Banking Group...	05/09
RBC Adjusts Price Target on Humana to $400 From $385, Maintains Outperform Rating	05/09	MT
Transcript : Humana Inc. Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 08:00 AM	04/09
Humana, Evergreen Nephrology Launch Kidney Care Program	29/08	MT
Humana Inc. and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease	29/08	CI
JPMorgan Adjusts Price Target on Humana to $396 From $332, Maintains Neutral Rating	21/08	MT
Humana Maintains Quarterly Dividend at $0.885 Per Share; Payable Oct. 25 to Shareholders of Record Sept. 30	15/08	MT
The latest transactions by star managers	15/08
Humana Inc. Declares Cash Dividend, Payable on October 25, 2024	15/08	CI
Wells Fargo Raises Humana's Price Target to $387 From $350	14/08	MT
Deutsche Bank Adjusts Humana Price Target to $349 From $341, Maintains Hold Rating	02/08	MT
TD Cowen Cuts Humana's Price Target to $402 From $407	02/08	MT
Cantor Fitzgerald Adjusts Price Target on Humana to $395 From $360	01/08	MT
Jefferies Adjusts Price Target on Humana to $419 From $365	01/08	MT
Barclays Adjusts Price Target on Humana to $364 From $370	01/08	MT
Bernstein Adjusts Price Target on Humana to $405 From $357	01/08	MT
Oppenheimer Adjusts Price Target on Humana to $400 From $370	01/08	MT
Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost	01/08	RE
Equities Rise as Fed Chair Powell Says September Rate Cut 'Could be on The Table'	01/08	MT
Equities Rise After Fed Chair Powell Says September Rate Cut Possible	01/08	MT
Sector Update: Health Care Stocks Softer in Late Afternoon Trading	01/08	MT
Top Midday Decliners	01/08	MT
Tranche Update on Humana Inc.'s Equity Buyback Plan announced on February 15, 2024.	31/07	CI
Sector Update: Health Care Stocks Edge Up in Afternoon Trading	31/07	MT

Humana Inc.

Equities

HUM